From September 1954 through December 1963, 1,705 patients with squamous cell carcinoma on intact uterus have had external irradiation given with a 22 MeV beam. This series of patients will be the main subject of this paper.
The following substaging has been found useful:
Stage IIA: Involvement of vagina or medial parametria. Stage IIB: Lesion occupying more than half of the pelvis. Stage IIIA: Involvement of one pelvic wall or lower third of the vagina. Stage IIIB: Both pelvic walls or one pelvic wall and lower third of the vagina.
Whole pelvis irradiation is used extensively from Stage IIB on, and also in Stages I and IIA when the vault is distorted because of old age or bulkiness of the disease. The radium system is a modification of the Manchester system. Since 1961, after-loading applicators have been used (Fig 1) . The general policies of treatment are "This investigation was supported by Public Health Service Research grants No. CA-06294 and CA-05654 from the National Cancer Institute. summarized in Table 1 . Because of the linear or T-shape arrangement of the radioactive sources, the gradient of dose falls off precipitously from the surface of the tandems and from colpostats toward the periphery of the pelvis and no point Table 1 M D Anderson Hospital techniques of radiotherapy for carcinoma of the uterine cervix-Stage TreatmentE I 8,000 to 10,000 mgh in two to four insertions in two to four weeks; 3,000 to 4,000 rads to parametria and regionallymphatics IIA Same as for Stage I IIB 4,000 rads to whole pelvis in four weeks, followed by 5,500 to 6,500 mgh in two insertions in two weeks
Exceptions
If the cervical lesion is large, 2,000 to 4,000 rads are given first to the whole pelvis to secure optimal geometric conditions for intracavitary radium therapy If patient is pregnant or is up to one year post-partum,, 4,000 rads are given to the whole pelvis because of increased probability of metastatic disease in the regionallymphatics Same as for Stage I IIIA 5,000 rads to whole pelvis in five weeks, followed by 4,000 to 5,000 mgh in one or two insertions IIIB 7,000 rads to whole pelvis in seven weeks with the 22 MeV betatron, the last 2,000 rads being given through 12 x 12 cm AP and PA portals IV Same as IIIB ifradical ti eatment is justified * Simplified from Fletcher (1 966a) * With the 22 MeV betatron, the depth dose at 10 cm is 80%.
When the total dose is no more than 4,000 rads, two parallel opposing portals are used; lateral portals are added if 4,000 rads are exceeded.
If only a "OCo unit or X-ray generators up to 6 MeV are available, a total dose of4,000 rads rarely should be exceeded 391 5 Proc. roy. Soc. Med. Volume 61 April 1968 Fig I From left to right: Regular tandems, ovoidls (2 cm diameter) with plastic jackets which are used to increase the size to medium (2 5 cm diameter) and large (3 cm diameter); the tandems are of various lengthls; difJerent types offlanges are available to miieet varying anatomic situations. Plastic ovoids and uterine sound used in the radium measurement clinic for planning the actual radium insertion. Afterloading tandem designed bv Sulit with insert, spacers, and dunmny metal sources of the same length as the radium tubes; the metal ring is placed at the external os; tandems of various curvatures should be available. Afterloading ovoids with inserters, lesigned by Suit, are on the far right. Radiographs of the implant are taken with metal dummies in order to determtine the number of sources needed to avoid a gap between the uterine and the vaginal radium sources into the vagina. The radium tubes are then inserted into the flexible plastic tube. Microcurie radium sources are used in the oper-ating room for bladder and rectal dose measuirements. (Reprodulcedfrom Fletcher 1966a by kindpermtission) and IV 7,000 *Use whichever maximum occurs first, either the time or the mgh * May be exceeded in large radium systems ifthere is too large a separation or for unusual tumour size or location (e.g. posterior or anterior lip, &c.) A May use the longer time first if the fix st application is unusually good and second application may not be as good T Ifthe status ofcentral disease indicates it, the time may be increased beyond 72 hours ifthere is a small radium system, resulting in low milligram hours. Then split into 48 hours -2 weeks -24 to 48 hours Note: A tandem with a protruding source and a 3 cm diameter vaginal cylinder should have a 20 mg sourc: in the cylinder with one and a half sources protruding. Theloading is 15-10-20; 15-10-10-20, &c. X Whole pelvis irradiation may be carried to 5.000 rads ifslow regression Table 2 ).
The survival rates at five and ten years by stages and sub-stages are shown in Table 3 for the squamous cell carcinomas on intact uterus. The survival rates for stump carcinomas are in the same range. Table 3 shows that few patients in the early stages of disease died because of the disease after five years. In the late stages, reactivation of disease within the pelvis and distant metastases will happen between five and ten years.
In addition to survival rates, it is important to analyse the sites of failure (Fletcher 1966b , Paunier et al. 1967 (Table 4 ). Deaths from com- Paunier et al. (1967) plications attributable to treatment are grouped together with pelvic failures; actually more than half of the patients who died from complications also had active disease.
The incidence of central failure, i.e., failures to control disease on the vault or the remaining uterus or immediate parametria, is very low ( Table 5) . A radical hysterectomy was attempted in a few patients who clinically had localized active disease; only 10% of these patients are alive with no evidence of disease.
Lymphadenectomy series: Because of the uncertainty about the control of involved nodes by radiation therapy, a randomized study of lymphadenectomy three months after the completion of the radical radiotherapy was done (Rutledge et al. 1965) . The results show that: (1) The incidence of involved nodes in the regional lymphatics was much lower than the one reported in the literature. (2) Very few patients who had positive nodes survived. (3) The patients without lymphadenectomy and those with lymphadenectomies had essentially the same survival rates. After analysis of the results of this study, lymphadenectomies were discontinued.
Bulky lesions: In studying the various clinical features or patterns of spread of the disease, it was found that the patients with massive central lesions, primarily those producing a barrelshaped uterus because of involvement of the isthmus, had a worse outlook. A programme of added simple hysterectomy following radical radiotherapy without lymphadenectomy is under way.
Adenocarcinoma of the cervix: Ninety-seven patients with adenocarcinoma originating on the cervix have been treated by irradiation only or by irradiation followed by hysterectomy.
Because, as a rule, adenocarcinoma of the cervix originates in the endocervix, grows locally extending into the lower uterine segment, the tumour at the periphery of the distended myometrium might not be irradiated adequately by the intracavitary radium. A post-irradiation simple total hysterectomy can remove tumour that has extended upward in the corpus.
The survival rates are 945 Y0 in Stage I, 65 % in Stage II, and 25 % in Stage IIl. When the patients treated by combination therapy are compared with the total number of patients seen and treated in each stage, there is no clear-cut superiority of combination therapy.
Cervical cancer in pregnancy or in the postpartum period: Prior to the availability of megavoltage, the survival rates for patients with cancer not only during pregnancy but also with diagnosis up to one year post-partum were about half the rates for the rest of the patients. Since 1954, 4,000 rads to the whole pelvis are always given in the patients with Stage I and Stage IIA lesions. The survival rates in those patients so treated are not significantly different from the over-all survival rates.
Complications: High dose whole pelvis irradiation alone or combined with intracavitary radium therapy is close to the maximum tolerance. The classical complications due to intracavitary radium therapy are rectal ulcers at the level of the posterior fornix, bladder ulcers, and recto-and vesico-vaginal fistulk. Rectosigmoiditis, sigmoiditis, and small bowel complications are essentially caused by external irradiation (Fletcher et al. 1966) . In 1959, the change from the roentgen to the rad added 7% to the dose given. This relatively small increase in dose produced a significant increase in the incidence and severity of complications.
Therefore great care must be exercised in the use of whole pelvis irradiation with attention to all the factors involved, i.e. dose determination, the true size of the portal (penumbra to be considered) and the pelvic structures covered. For Stage IIB and favourable Stage IIIA cases, doses probably should not exceed 4,000 rads to the whole pelvis provided there is an anatomy suitable for effective intracavitary radium therapy.
Discussion and Summary
Intracavitary radium therapy is still the best form of radiotherapy for localized cancer on and around the cervix. Megavoltage roentgentherapy assumes an increasingly important role in more advanced stages of the disease and also in those patients with unfavourable anatomy for intracavitary radium therapy.
